RiVax: Completed Phase Ib enrollment

Soligenix completed enrollment of about 20 healthy volunteers in an open-label, U.S. Phase Ib trial to evaluate 3 undisclosed intramuscular doses of RiVax administered with an aluminum adjuvant given ...